Results 161 to 170 of about 25,099 (263)

Antidromic vasodilatation and inhibitors of cholinesterase [PDF]

The Journal of Physiology, 1953
openaire   +2 more sources

Fluorometric and Colorimetric Biosensors for the Assay of Cholinesterase Inhibitors. [PDF]

Sensors (Basel)
Pohanka M.
europepmc   +1 more source

Role of cholinesterase inhibitors in Parkinson\u27s disease and dementia with Lewy bodies

This article reviews the cholinergic changes in Parkinson\u27s disease and dementia (PDD) and dementia with Lewy bodies (DLB), their potential clinical implications, and the available evidence for cholinesterase inhibitors in the treatment of PDD and DLB.
Mosimann UP, McKeith IG, Aarsland D
core  

Novel tacrine derivatives containing pyrazole scaffold, as potential cholinesterase inhibitors

Alzheimer’s disease (AD) is a progressive neurodegenerative disease with a fatal outcome, and the most common type of dementia. Cholinesterase inhibitors, which inhibit the enzymes responsible for the breakdown of acetylcholine (ACh) an important ...
Kostić-Rajačić, Slađana, Andrić, Deana, Penjišević, Jelena, Šukalović, Vladimir, Krunić, Mihajlo, Jevtić, Ivana   +5 more
core   +1 more source

Photoredox-enabled late-stage functionalization of pyrrolidines in batch and flow: rapid access to benzothiazole hybrids as a new class of cholinesterase inhibitors. [PDF]

RSC Adv
Filipović A, Vučkovski M, Mićović D, Bondžić AM, Bondžić BP.   +4 more
europepmc   +1 more source

Two selective inhibitors of cholinesterase [PDF]

Biochemical Journal, 1953
L, AUSTIN, W K, BERRY
openaire   +3 more sources

Integrated in silico identification of cholinesterase inhibitors from Nyctanthes arbor-tristis. [PDF]

PLoS One
Jamal QMS, Alharbi AH, Ahmad V, Ahmad K.
europepmc   +1 more source

Comparative safety of cholinesterase inhibitors and memantine for dementia: a protocol for a network meta-analysis of randomized controlled trials. [PDF]

Syst Rev
Abouelmagd ME, Almosilhy NA, Makhlouf HA, Hassan AK, Osman ASA, Hindawi MD, Elshahat A, Alnajjar AZ, Mustafa MMM, Abdelsalam OK, Mady A, Shaheen A, Barrett MJ, Negida A.   +13 more
europepmc   +1 more source

Cholinesterase inhibitors in advanced Dementia with Lewy bodies: increase or stop?

Introduction There is little data on stopping cholinesterase inhibitors in Dementia with Lewy bodies (DLB). Equally, it is not known if increasing the dose of cholinesterase inhibitors may help neuropsychiatric symptoms in advanced DLB.
Cousins DA, Pakrasi S, Mosimann UP, Thomas A, O'Brien JT, Lett D, McKeith IG, Burn DJ   +7 more
core  

Novel cinnamic acid-based <i>N</i>-benzyl pyridinium analogs: potent dual cholinesterase inhibitors with neuroprotective properties for Alzheimer's disease. [PDF]

RSC Adv
Esmkhani M, Mahdavi M, Javanshir S, Iraji A.   +3 more
europepmc   +1 more source